Sexual violence perpetrated by health professionals

Sexual violence (SV) perpetrated by health professionals concerns any sexual conduct, whether physical or verbal (with or without contact), toward a patient. There has been little scientific study and some disagreements have emerged regarding its definition, which has even been confused with violation of professional boundaries. In this descriptive-exploratory study, we aimed to characterize this phenomenon in the Portuguese context, using a sample of 491 participants who completed an online questionnaire adapted for this study. The results showed that 8.96% of the participants (5.5% indirect victims) suffered SV by a health professional, and the sociodemographic characteristics are very similar to those of SV in other contexts. Thus, after confirming this is not a problem alien to the Portuguese reality, we discuss the practical implications for prevention and intervention with victims

The Relationship Between Professional Sexual Boundary Violation And Sex Addiction: An Exploratory Study Of Post-treatment And Retrospective Pre-treatment Dispositions

In this exploratory study, 35 male professionals who had successfully completed residential sex addiction treatment were surveyed. Respondents’ median age was 47.5, and reported ethnicities were White (89%), Asian, (9%) and Hispanic (2%). Prior to intake, 17 respondents had reportedly violated sexual boundaries with patients, clients, or staff (BV group) and 18 reportedly had not (NBV group). Respondents completed a demographic information form and two validated instruments: (a) Sexual Symptom Assessment Scale (S-SAS), measuring symptom severity of Compulsive Sexual Behavior (CSB); and (b) Boundary Violation Index (BVI), assessing frequency of risk factors for Sexual Boundary Violation (SBV). Respondents reported a very large decrease in CSB symptom severity over time (partial 2 = .856), change that was statistically equal for respondents in the BV and NBV groups. Furthermore, respondents reported a large decrease in SBV risk over time (partial 2 = .620); however, the BV group reported a greater decrease in SBV risk than the NBV group (partial 2 = .221). Reductions in both CSB symptoms and SBV risk were stable over time, up to five years post discharge. CSB symptoms and SBV risk were not correlated at retrospective pre-treatment, but for practical purposes, were moderately correlated at post treatment (r = 0.386, n = 25, p = 0.057). Although not significant, correlation at pre-treatment was more than twice as strong for the BV group than for the NBV group. Days of Treatment was a meaningful, although non-significant, contributor to decreases in CSB symptom severity (? = -.323). Similarly, Days of Treatment (? = -.785), Counseling (? = -.303), Recovery Support (? = -.292), and Continuing Education (? = -.259) were meaningful, although non-significant, contributors to decrease in SBV risk. At study participation, 77.1% of respondents had reportedly retained their professional licenses, although 15.4% reported having received a new licensing board complaint. Clinical and professional implications, limitations, and areas for future research are discussed